Clinical trial NCT05992467: WECARE: A Behavioral Intervention for Dementia Caregivers
Official title: WECARE: A mHealth Intervention to Enhance Caregiving Mastery Among Chinese American Dementia Caregivers
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Caregiver Burden
Caregiver Stress Syndrome
Lead sponsor: George Mason University
Sponsor class: OTHER
First posted: 2023-08-15
Enrollment: 48
Sex: ALL
Minimum age (years): 21
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: This study aims to pilot test a culturally tailored behavioral intervention called "WECARE" to enhance caregiving mastery and improve psychosocial wellbeing of Chinese American family caregivers of persons with Alzheimer's Disease and related dementia.

Detailed description: The investigators propose to test a culturally tailored mHealth behavioral intervention to enhance caregiving mastery and improve psychosocial wellbeing among Chinese American family caregivers of persons living with Alzheimer's Disease and related dementia. This intervention, Wellness Enhancement for Caregivers (WECARE), will be delivered via WeChat, a social media app highly popular among Chinese Americans. About 45 participants will be recruited for the pilot test. Participants will complete a baseline survey, receive 7-week WECARE program on their WeChat accounts, complete a follow-up survey 12 weeks after the baseline, and then a qualitative interview on Zoom.

Eligibility criteria: Inclusion Criteria:

1. 21 years or older,
2. self-identified as Chinese or Chinese American,
3. speak and read Chinese (Mandarin or Cantonese),
4. own a smartphone and use WeChat,
5. living in Washington DC metropolitan, and
6. currently care for a family member with ADRD and provide care for at least 10 hours a week.

Exclusion Criteria:

1. do not read or speak Chinese,
2. care-recipient is in hospice care or have a life expectancy less than 6 months,
3. signs of severe intellectual deficits or psychotic disorders, or
4. unable to provide informed consent.

Primary outcomes:
measure: Efficacy of behavioral intervention in change from baseline in depressive symptoms
timeFrame: Baseline (before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention
Secondary outcomes:
measure: Efficacy of behavioral intervention in change from baseline in caregiving burden
timeFrame: Baseline (before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention
measure: Efficacy of behavioral intervention in change from baseline in life satisfaction
timeFrame: Baseline (before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention
Other outcomes:
measure: Efficacy of behavioral intervention in change from baseline in caregiving mastery
timeFrame: Baseline (before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention
measure: Efficacy of behavioral intervention in change in care-recipient's problem behaviors
timeFrame: Baseline (before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention
measure: Efficacy of behavioral intervention in change from baseline in positive aspect of caregiving
timeFrame: Baseline (before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention.
Locations:
city: Fairfax
country: United States
facility: George Mason University
state: Virginia
Study officials:
References: